Year None2023202220212020201920182017201620152014201320122011201020092008 Feb 02, 2023 Agios to Webcast Conference Call of Fourth Quarter and Year End 2022 Financial Results on Feb. 23, 2023 Read More PDF Version Jan 08, 2023 Agios Unveils 2023-2026 Value-driving Catalysts Enabling Company’s Vision to Transform Patient Outcomes in Rare Diseases Read More PDF Version Jan 03, 2023 Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer Read More PDF Version Pagination First page « first Previous page ‹ previous Page 1 Page 2 Current page 3 Displaying 21 - 23 of 23
Feb 02, 2023 Agios to Webcast Conference Call of Fourth Quarter and Year End 2022 Financial Results on Feb. 23, 2023 Read More PDF Version
Jan 08, 2023 Agios Unveils 2023-2026 Value-driving Catalysts Enabling Company’s Vision to Transform Patient Outcomes in Rare Diseases Read More PDF Version
Jan 03, 2023 Agios Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Commercial Officer Read More PDF Version
